Westside Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$340K Sell
6,990
-952
-12% -$46.3K 0.06% 199
2025
Q1
$269K Buy
7,942
+1,790
+29% +$60.7K 0.06% 202
2024
Q4
$242K Sell
6,152
-290
-5% -$11.4K 0.05% 210
2024
Q3
$308K Sell
6,442
-1,021
-14% -$48.8K 0.07% 187
2024
Q2
$403K Buy
7,463
+70
+0.9% +$3.78K 0.09% 156
2024
Q1
$504K Buy
7,393
+332
+5% +$22.6K 0.12% 143
2023
Q4
$442K Buy
7,061
+50
+0.7% +$3.13K 0.11% 150
2023
Q3
$318K Hold
7,011
0.09% 167
2023
Q2
$394K Sell
7,011
-119
-2% -$6.68K 0.11% 155
2023
Q1
$322K Sell
7,130
-600
-8% -$27.1K 0.09% 169
2022
Q4
$27.3K Hold
7,730
0.07% 153
2022
Q3
$43.6K Hold
7,730
0.1% 133
2022
Q2
$44.1K Sell
7,730
-200
-3% -$1.14K 0.1% 134
2022
Q1
$44.1K Buy
7,930
+270
+4% +$1.5K 0.1% 134
2021
Q4
$44K Buy
7,660
+3,910
+104% +$22.4K 0.1% 132
2021
Q3
$43.8K Buy
3,750
+840
+29% +$9.81K 0.1% 130
2021
Q2
$39.3K Buy
2,910
+100
+4% +$1.35K 0.09% 133
2021
Q1
$29.6K Buy
2,810
+2,510
+837% +$26.4K 0.08% 132
2020
Q4
$30.6K Sell
300
-100
-25% -$10.2K 0.08% 116
2020
Q3
$25.1K Sell
400
-212
-35% -$13.3K 0.01% 120
2020
Q2
$22.1K Sell
612
-250
-29% -$9.02K 0.01% 103
2020
Q1
$25.5K Buy
+862
New +$25.5K 0.02% 112
2019
Q2
$4 Buy
+100
New +$4 ﹤0.01% 564
2018
Q4
$2.86K Hold
100
﹤0.01% 604
2018
Q3
$4.23K Hold
100
﹤0.01% 609
2018
Q2
$6.01K Buy
+100
New +$6.01K ﹤0.01% 653
2018
Q1
Sell
-100
Closed -$2.61K 809
2017
Q4
$2.61K Hold
100
﹤0.01% 765
2017
Q3
$1.97K Hold
100
﹤0.01% 751
2017
Q2
$1.6K Hold
100
﹤0.01% 755
2017
Q1
$1.99K Buy
+100
New +$1.99K ﹤0.01% 713